Hillsdale Investment Management Inc. Increases Holdings in Maximus, Inc. (NYSE:MMS)

Hillsdale Investment Management Inc. boosted its position in Maximus, Inc. (NYSE:MMS) by 0.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 52,400 shares of the health services provider’s stock after purchasing an additional 230 shares during the period. Hillsdale Investment Management Inc. owned about 0.09% of Maximus worth $3,912,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Reinhart Partners LLC. raised its stake in shares of Maximus by 43.5% during the 4th quarter. Reinhart Partners LLC. now owns 551,146 shares of the health services provider’s stock worth $41,143,000 after buying an additional 167,019 shares during the last quarter. Sio Capital Management LLC purchased a new position in Maximus during the 3rd quarter valued at about $14,453,000. Ruffer LLP acquired a new position in Maximus during the fourth quarter worth about $10,266,000. Barclays PLC lifted its holdings in shares of Maximus by 285.1% in the third quarter. Barclays PLC now owns 170,971 shares of the health services provider’s stock valued at $15,927,000 after purchasing an additional 126,573 shares in the last quarter. Finally, Empowered Funds LLC acquired a new stake in shares of Maximus in the fourth quarter valued at approximately $8,139,000. 97.21% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Maximus news, Director Jan Madsen sold 2,439 shares of the stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the transaction, the director now owns 18,097 shares of the company’s stock, valued at $1,225,347.87. This trade represents a 11.88 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Ilene R. Baylinson sold 14,500 shares of the business’s stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the sale, the insider now directly owns 2,512 shares of the company’s stock, valued at $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

MMS has been the subject of several research reports. StockNews.com downgraded Maximus from a “buy” rating to a “hold” rating in a research report on Friday, February 14th. Raymond James upgraded Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective on the stock in a research report on Thursday, January 2nd.

Maximus Stock Performance

Shares of NYSE MMS opened at $67.12 on Friday. The company has a 50-day simple moving average of $71.07 and a 200-day simple moving average of $78.55. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The company has a market cap of $3.80 billion, a PE ratio of 14.43 and a beta of 0.71. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.97.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. On average, equities analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Saturday, February 15th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 1.79%. Maximus’s dividend payout ratio (DPR) is presently 25.81%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.